Results 301 to 310 of about 397,364 (338)

Enhanced THBS2 promotes collagen synthesis and inflammatory secretome of fibroblasts in idiopathic pulmonary fibrosis. [PDF]

Sci Rep
Yu L, Wang R, Hou Q, Yang F, Liu Y, Peng M, Dong Y, Liu Y, Cheng Z.   +8 more
europepmc   +1 more source

Temporo-spatial cellular atlas of the regenerating alveolar niche in idiopathic pulmonary fibrosis. [PDF]

Nat Commun
Weeratunga P, Hunter B, Sergeant M, Bull J, Clelland C, Denney L, Vuppusetty C, Burgoyne R, Woo J, Hu T, Borthwick L, Shaw J, Antanaviciute A, Filby A, Byrne H, Fisher A, Ho LP.   +16 more
europepmc   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis. [PDF]

World J Clin Cases
Xu LY, Yu Y, Cen LS.
europepmc   +1 more source

The potential clinical implications of slow vital capacity in patients with idiopathic pulmonary fibrosis. [PDF]

Respir Res
Kim HC, Guthrie S, King CS, Khan S, Thomas CA, Khangoora V, Nathan SD.   +6 more
europepmc   +1 more source

TTN‐related dilated cardiomyopathy in a patient with positive unknown familiarity for heart failure and bicuspid aortic valve

ESC Heart Failure, EarlyView.
Simone Sarzilla, Elia Rigamonti, Laura Anna Leo, Francesca Romana Scopigni, Giorgio Moschovitis   +4 more
wiley   +1 more source

Idiopathic Pulmonary Fibrosis [PDF]

New England Journal of Medicine, 2018
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.
Poletti Venerino, Tomassetti S, Ravaglia Claudia   +2 more
openaire   +8 more sources

Some of the next articles are maybe not open access.

Related searches:

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Immunology and Allergy Clinics of North America, 2023
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes.
Rachel, Strykowski, Ayodeji, Adegunsoye
openaire   +2 more sources

Idiopathic Pulmonary Fibrosis

Annual Review of Medicine, 1993
Idiopathic pulmonary fibrosis kills half of its victims within five years of diagnosis. Currently available treatment regimens are disappointing, and the incidence of the disease appears to be increasing. Newer techniques of imaging coupled with laboratory advances in molecular and cellular biology may produce new strategies for modulating the disease ...
Owen J, Dempsey, David, Miller
openaire   +3 more sources